Baidu
map

Movement Disorder: 帕金森患者,脑白质病变和病情进展密切相关

2022-01-14 Freeman MedSci原创

在PD中,WMHs和认知恶化之间存在关联

在最常见的白质(WM)宏观结构改变中,白质高信号(WMHs)在T2加权磁共振成像(MRI)扫描中很容易识别。WMHs与年龄增长和正常老化的认知能力下降有关。在帕金森病(PD)中,先前横断面研究的证据表明,WMH总体积与认知和/或运动障碍之间存在关联。以前的一项纵向MRI研究显示,帕金森病患者的运动或认知能力下降与WMH体积增加之间没有关联。

WM微结构的改变也与PD的神经变性有关。使用弥散张量(DT)MRI的横断面研究显示,弥散的WM微结构损伤与PD患者的运动和认知障碍程度有关。只有少数研究调查了弥散张量MRI改变的纵向演变,显示弥散各向异性(FA)的减少和平均弥散率(MD)的增加,反映了PD的严重性。

然而,这些研究评估的是全脑WM,并没有考虑影响DT MRI指标的WMHs的位置和严重程度。只有少数报告专门评估了PD中正常外观白质(NAWM)的参与情况,他们没有发现PD患者与健康对照组相比有明显的改变,也没有发现与临床特征有任何关联。


藉此,意大利IRCCS San Raffaele Scientific Institute的Pietro Giuseppe Scamarcia等人,系统地探究了WMHs和NAWM DT MRI改变的演变,以及它们与大群PD患者运动和认知障碍进展的关系,并进行长达4年的纵向跟踪。

共有154名帕金森病患者每年接受一次临床、认知和磁共振成像(MRI)评估,为期4年。60名健康对照组在基线时接受了同样的方案。确定了WMH,并测量了WMH的总体积。WMH也被用作排除掩码来定义正常外观的白质(NAWM)。使用基于TBSS,获得全脑WM和NAWM的弥散张量(DT)MRI指标。线性混合效应模型定义了变量之间的纵向演变和关联。使用线性回归和Cox比例危害模型测试了WM改变作为疾病进展的风险因素。

他们发现:在基线时,与对照组相比,PD患者的所有DT MRI指标都出现了改变。

纵向来看,DT MRI指标没有明显变化,也没有发现与临床变量的关联。WMH体积随时间变化,并与整体认知、执行功能和语言的损害有关。基线WMH体积是进展为轻度认知障碍的一个中等风险因素。

该研究的重要意义在于发现了:在PD中,WMHs和认知恶化之间存在关联,而WM微结构损伤对临床恶化的贡献可忽略不计。通过MRI评估的WMHs可以为监测PD患者认知障碍的发展提供一个重要工具。



原文出处:
Scamarcia PG, Agosta F, Spinelli EG, et al. Longitudinal White Matter Damage Evolution in Parkinson’s Disease. Mov Disord. Published online November 22, 2021:mds.28864. doi:10.1002/mds.28864

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-02-03 cmsvly
  4. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1659286, encodeId=fbfa165928628, content=<a href='/topic/show?id=af9384966c9' target=_blank style='color:#2F92EE;'>#脑白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84966, encryptionId=af9384966c9, topicName=脑白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72ee24960132, createdName=xre2016, createdTime=Sun Jun 12 08:58:33 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077670, encodeId=064620e7670a7, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Thu May 12 19:58:33 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784484, encodeId=e19c1e8448473, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Thu Feb 03 07:58:33 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765169, encodeId=1c7a1e651694c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 09 19:58:33 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013794, encodeId=e2442013e946c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Sep 29 07:58:33 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765941, encodeId=1b111e65941b1, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Jun 22 15:58:33 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526573, encodeId=0ed515265e3b9, content=<a href='/topic/show?id=5678e181141' target=_blank style='color:#2F92EE;'>#白质病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71811, encryptionId=5678e181141, topicName=白质病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fcf11728516, createdName=gongliu, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596790, encodeId=d7101596e9072, content=<a href='/topic/show?id=866184965c7' target=_blank style='color:#2F92EE;'>#脑白质病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84965, encryptionId=866184965c7, topicName=脑白质病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ab18418561, createdName=天堂的云, createdTime=Thu Jan 13 13:58:33 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

相关资讯

Mov Disord:DTI研究发现丘脑背内侧核游离水与帕金森病认知能力下降相关

丘脑背内侧核 FW是一种有希望的早期帕金森病认知进展的生物标志物,有助于临床试验中识别认知保护疗法。FW是这些结果的可靠评估模式。

JAMA Neurology: COMT抑制剂对帕金森左旋多巴疗法辅助效果不佳

与MAO-B抑制剂或多巴胺激动剂作为左旋多巴治疗不可控PD患者的辅助治疗相比,COMT抑制剂的患者分级生活质量更差。

JNNP:帕金森病奖励处理中断及其与多巴胺状态和神经精神综合征的关系-系统评价和荟萃分析

帕金森病 (PD) 是全球增长最快的神经系统疾病 ,估计每年的社会成本与痴呆症相当。 传统上被概念化为运动障碍,非运动症状,包括情绪、认知和动机的中断,很常见,而且比运动症状对健康相关生活质量的负面影

Front.aging-neurosci-FGF21调节小胶质细胞极化,减弱帕金森病小鼠和细胞模型的神经变性

帕金森病 (PD) 是一种与年龄相关的神经退行性疾病,其特征是中脑多巴胺能神经元的慢性变性。PD 过程的确切机制尚不清楚,迫切需要新的早期检测标志物和治疗靶点

帕金森病进展期运动症状管理和非运动症状管理

2021年9月17日至22日,国际帕金森病与运动障碍(MDS)学术大会以线上会议形式举行,带来了帕金森病(PD)进展期运动症状管理和非运动症状管理。

Neurology:帕金森病患者前额叶皮质血氧水平依赖性(BOLD)变异性反映环境适应应变性和习得稳定性有限

近日,研究人员通过比较普通行走和双任务行走评估任务难度对HBO2变异性的影响,将增加的HBO2变异性与对环境挑战的灵活适应、降低的HBO2变异性与性能的稳定性联系起来。结果表明,两个概念在PD作用有限

拓展阅读

好文推荐 | 帕金森病的脑血流调节研究进展

本文通过回顾文献,重点总结PD患者的脑血流调节机制:脑血流自动调节、血管舒缩反应、神经血管耦合、内皮依赖性反应,为探讨脑血流对帕金森病的影响提供新思路和方向。

AM:山东大学仇吉川等团队揭示纳米电极介导的细胞外电刺激途径增强帕金森病治疗效果

该研究将电化学剥离的石墨烯纳米片锚定在NSC膜上,用作无线纳米电极。

好文推荐 | 脑深部电刺激术对帕金森病患者眼球运动影响的研究进展

DBS对眼球运动的影响可能为我们提供关键线索,以了解DBS的作用机制,以及受刺激的基底神经节部分的生理功能。本文对这一领域的研究进展进行综述。

帕金森病的睡眠问题:从RBD到不宁腿!

正确认识PD睡眠障碍的类型、病因及治疗方案,将有助于PD睡眠障碍的有效治疗。

JNNP:长期太极拳训练对帕金森病的影响:3.5年随访队列研究

太极拳训练对帕金森病具有长期有益作用,可改善运动和非运动症状,减少并发症。

2024 NICE 介入程序指南:磁共振成像(MRI)引导的聚焦超声丘脑底核切开术用于治疗帕金森病 [IPG797]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-12-18

2024 NICE 介入程序指南:磁共振成像引导的聚焦超声丘脑切开术用于治疗帕金森病中重度震颤 [IPG796]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-12-18

Baidu
map
Baidu
map
Baidu
map